Conavi Medical Corp. logo

Conavi Medical Corp. (YU1)

Market Closed
XBER XBER
19.25M Market Cap
- P/E Ratio
- Div Yield
- Volume
- Eps
Previous Close
Day Range
0 0
Year Range
0 0
Want to track YU1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

YU1 is not paying dividends to its shareholders.
The stock of the company had never split.
The company's stock is traded on 1 different exchanges and in various currencies, with the primary listing on XBER (EUR).

YU1 Chart

Similar

7XB
Xbrane Biopharma AB (publ)
0.89
+6.92%
SG0
Fibrobiologics Inc.
-
-
MIE Holdings Corporation
0
0%
R1B
Rubean AG
4.88
-3.37%
PI6
Palvella Therapeutics Inc
-
-

Conavi Medical Corp. (YU1) FAQ

What is the stock price today?

The current price is €0.00.

On which exchange is it traded?

Conavi Medical Corp. is listed on XBER.

What is its stock symbol?

The ticker symbol is YU1.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, the market cap is 19.25M.

Has Conavi Medical Corp. ever had a stock split?

No, there has never been a stock split.

Conavi Medical Corp. Profile

Health Care Technology Industry
Healthcare Sector
Mr. Thomas Looby CEO
XBER Exchange
- ISIN
Canada Country
- Employees
- Last Dividend
- Last Split
- IPO Date

Overview

Conavi Medical Corp. is a pivotal player in the cardiovascular medical field, primarily focusing on the innovation, manufacture, and distribution of advanced imaging technologies aimed at guiding minimally invasive cardiovascular interventions. Based in Toronto, Canada, the company leverages cutting-edge technological advancements to foster enhancements in the safety, efficacy, and precision of cardiac procedures. By specializing in merging traditional and novel imaging modalities, Conavi is at the forefront of facilitating comprehensive visualization methods to healthcare professionals, thus contributing significantly to the evolution of cardiovascular care.

Products and Services

  • Novasight Hybrid System – This flagship offering represents a significant leap in intracardiac imaging technologies. By integrating intravascular ultrasound (IVUS) with optical coherence tomography (OCT), the Novasight Hybrid System delivers simultaneous and co-registered images of the coronary arteries. This dual-modality approach allows for unparalleled clarity and precision, enabling clinicians to make more informed decisions during interventions. The system's innovation lies in its capability to provide a comprehensive view of the vasculature, combining the depth penetration of IVUS and the high-resolution detail of OCT. This synthesis facilitates a better understanding of coronary artery conditions, thereby enhancing procedural outcomes and patient care.

Contact Information

Address: 293 Lesmill Road
Phone: -